23andMe's 'Build-a-Baby' Patent Criticised
By BBC,
BBC News [Quotes CGS's Marcy Darnovsky]
| 10. 03. 2013
A US patent for a database that uses DNA testing to tell prospective parents which traits their future offspring may inherit has been criticised by experts.
23andMe says its Family Traits Inheritor Calculator can predict the risk of inheriting specific diseases as well as details such as height, weight, eye colour and even personality.
Couples send the firm a saliva sample to see what their babies might be like.
But critics have called the project "ethically and socially treacherous".
Designer babies
The patent suggests the database could also be used by fertility clinics to find appropriate donors.
But the Mountain View, California-based firm was quick to say this was no longer part of its plan.
"At the time 23andMe filed the patent, there was consideration that the technology could have potential applications for fertility clinics so language specific to the fertility treatment process was included in the patent," it said in a blog post.
"The company never pursued the concepts discussed in the patent beyond our Family Traits Inheritance Calculator, nor do we have any plans to do...
Related Articles
By Natalie Ram, Anya E. R. Prince, Jessica L. Roberts, Dov Fox, and Kayte Spector-Bagdady, Science | 09.11.2025
After declaring bankruptcy in March 2025, direct-to-consumer (DTC) genetic testing company 23andMe sold the data of more than 15 million people around the world to TTAM Research Institute, a nonprofit organization created by 23andMe’s founder and long-time CEO. 23andMe’s customers...
By Gina Kolata, The New York Times | 09.22.2025
On May 26, Tracy Atteberry checked in to the hospital at the National Institutes of Health in Bethesda, Md. The 57-year-old has an ultrarare inherited disease that hobbles his immune system so that the most innocuous of germs could kill...
By Dennis Sponer, BioSpace | 09.03.2025
Imagine telling a child with sickle cell disease that a cure exists—but it’s too expensive for their insurer to cover. That’s not a hypothetical. It’s the reality of gene therapy today: a revolutionary medical breakthrough caught in the bottleneck of...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...